facebook  linkedin xpix

Diary Dates
Save the date for important iCMLf meetings and programs
calendar

Become a member

Become an iCMLf member - help shape our future
member-button

Please donate

Support our activities
by donating
Donate here

Supporters

We thank all our supporters and partners

supporter-lay2

If you are not a member, please click on "Register". If you have forgotten your password, please click on "Forgot login?" below.

06 SHC IME P

Latest advances from key CML publications

 

To keep you up-to-date in the clinical management on CML the iCMLf is pleased to present to you monthly updates from key CML publications. Stories deliver the latest research, findings, thoughts and opinions in the fast moving world of medical research and clinical trials ensuring you know 'what's hot'. 

Stories are based on articles published in international peer-reviewed journals, or conference sessions and written by highly experienced and knowledgeable writers. 

Articles contain full references, so you can easily find background information and further reading if desired.
This independent educational resource is provided as a special service by the iCMLf in partnership with Springer Healthcare IME and is supported by a grant from Novartis Oncology.

 

Read the CML stories of the month:

  • Imatinib molecular response depth determines impact of fluctuation

    Research suggests that the relationship between a fluctuating response to imatinib and the likelihood of developing resistance to the tyrosine kinase inhibitor depends on the depth of molecular response achieved by the CML patient.

    (Source: Br J Haematol, February 2017; advance online publication)
  • Efficacy suboptimal with first-line generic imatinib
    The efficacy of imatinib can be maintained when switching from a branded to generic formulation, but may be reduced when the drug is uses as a first-line treatment for CML, show results of a study from Bosnia and Herzegovina.

    (Source: Clin Lymphoma Myeloma Leuk, February 2017; advance online publication)

Read additional CML stories from previous months here

Click here to see a list of recent clinical and scientific publications from peer-reviewed journals